BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1669971)

  • 1. Toxicity equivalency factors for PCBs?
    Barnes D; Alford-Stevens A; Birnbaum L; Kutz FW; Wood W; Patton D
    Qual Assur; 1991 Oct; 1(1):70-81. PubMed ID: 1669971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment.
    Giesy JP; Kannan K; Blankenship AL; Jones PD; Hilscherova K
    Cent Eur J Public Health; 2000 Jul; 8 Suppl():43-5. PubMed ID: 10943457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment.
    Safe SH
    Crit Rev Toxicol; 1994; 24(2):87-149. PubMed ID: 8037844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs).
    Safe S
    Crit Rev Toxicol; 1990; 21(1):51-88. PubMed ID: 2124811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
    Simon T; Britt JK; James RC
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of TEFs for PCB congeners by using an alternative biomarker--thyroid hormone levels.
    Yang JM; Salmon AG; Marty MA
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):225-36. PubMed ID: 20043972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development validation and problems with the toxic equivalency factor approach for risk assessment of dioxins and related compounds.
    Safe SH
    J Anim Sci; 1998 Jan; 76(1):134-41. PubMed ID: 9464894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus toxicity factors for polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls combining in silico models and extensive in vitro screening of AhR-mediated effects in human and rodent cells.
    Larsson M; van den Berg M; Brenerová P; van Duursen MB; van Ede KI; Lohr C; Luecke-Johansson S; Machala M; Neser S; Pěnčíková K; Poellinger L; Schrenk D; Strapáčová S; Vondráček J; Andersson PL
    Chem Res Toxicol; 2015 Apr; 28(4):641-50. PubMed ID: 25654323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.
    Van den Berg M; Birnbaum LS; Denison M; De Vito M; Farland W; Feeley M; Fiedler H; Hakansson H; Hanberg A; Haws L; Rose M; Safe S; Schrenk D; Tohyama C; Tritscher A; Tuomisto J; Tysklind M; Walker N; Peterson RE
    Toxicol Sci; 2006 Oct; 93(2):223-41. PubMed ID: 16829543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.
    Wilkes JG; Hass BS; Buzatu DA; Pence LM; Archer JC; Beger RD; Schnackenberg LK; Halbert MK; Jennings L; Kodell RL
    Toxicol Sci; 2008 Mar; 102(1):187-95. PubMed ID: 18065775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the carcinogenicity of polychlorinated biphenyls (PCBs).
    Smith MA
    J Toxicol Environ Health; 1997 Apr; 50(6):567-79. PubMed ID: 15279030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioxins, dioxin-like PCBs and non-dioxin-like PCBs in foodstuffs: occurrence and dietary intake in The Netherlands.
    Baars AJ; Bakker MI; Baumann RA; Boon PE; Freijer JI; Hoogenboom LA; Hoogerbrugge R; van Klaveren JD; Liem AK; Traag WA; de Vries J
    Toxicol Lett; 2004 Jun; 151(1):51-61. PubMed ID: 15177640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polychlorinated biphenyl congeners as markers of toxic equivalents of polychlorinated biphenyls, dibenzo-p-dioxins and dibenzofurans in breast milk.
    Glynn AW; Atuma S; Aune M; Darnerud PO; Cnattingius S
    Environ Res; 2001 Jul; 86(3):217-28. PubMed ID: 11453672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment.
    Giesy JP; Kannan K
    Crit Rev Toxicol; 1998 Nov; 28(6):511-69. PubMed ID: 9861526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional Associations between Exposure to Persistent Organic Pollutants and Leukocyte Telomere Length among U.S. Adults in NHANES, 2001-2002.
    Mitro SD; Birnbaum LS; Needham BL; Zota AR
    Environ Health Perspect; 2016 May; 124(5):651-8. PubMed ID: 26452299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polybrominated dibenzo-p-dioxins, dibenzofurans, and biphenyls: inclusion in the toxicity equivalency factor concept for dioxin-like compounds.
    van den Berg M; Denison MS; Birnbaum LS; Devito MJ; Fiedler H; Falandysz J; Rose M; Schrenk D; Safe S; Tohyama C; Tritscher A; Tysklind M; Peterson RE
    Toxicol Sci; 2013 Jun; 133(2):197-208. PubMed ID: 23492812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of toxic equivalency factors for risk assessment for dioxins and related compounds.
    Birnbaum LS; DeVito MJ
    Toxicology; 1995 Dec; 105(2-3):391-401. PubMed ID: 8571375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical effects of polychlorinated biphenyls: an overview and identification of research needs.
    Tilson HA; Kodavanti PR
    Neurotoxicology; 1997; 18(3):727-43. PubMed ID: 9339820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure-activity relationship (QSAR).
    Ruiz P; Faroon O; Moudgal CJ; Hansen H; De Rosa CT; Mumtaz M
    Toxicol Lett; 2008 Sep; 181(1):53-65. PubMed ID: 18662755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.